These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 9225642

  • 1. Oral contraception and cerebral thromboembolism.
    Lidegaard O.
    Acta Obstet Gynecol Scand Suppl; 1997; 164():66-8. PubMed ID: 9225642
    [Abstract] [Full Text] [Related]

  • 2. [Oral contraceptives and cerebral thromboembolism. A Danish case-control study].
    Lidegaard O.
    Ugeskr Laeger; 1993 Nov 01; 155(44):3538-45. PubMed ID: 8236574
    [Abstract] [Full Text] [Related]

  • 3. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.
    Lidegaard O.
    BMJ; 1993 Apr 10; 306(6883):956-63. PubMed ID: 8490470
    [Abstract] [Full Text] [Related]

  • 4. The case for a lower dose pill. Assessing the impact of estrogen dose.
    Brown S, Cropfield O.
    ORGYN; 1995 Apr 10; (2):36-9. PubMed ID: 12319251
    [Abstract] [Full Text] [Related]

  • 5. [Use of oral contraceptives in Denmark 1980-1990 and smoking habits among fertile women in 1990].
    Lidegaard O.
    Ugeskr Laeger; 1993 Nov 01; 155(44):3550-8. PubMed ID: 8236576
    [Abstract] [Full Text] [Related]

  • 6. The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study.
    Hannaford PC, Kay CR.
    Br J Gen Pract; 1998 Oct 01; 48(435):1657-62. PubMed ID: 10071398
    [Abstract] [Full Text] [Related]

  • 7. [Decline in cerebral thromboembolism among younger women after introduction of low-dose oral contraceptives. A study of the incidence for the period 1980-1995].
    Lidegaard O.
    Ugeskr Laeger; 1996 Oct 14; 158(42):5933-9. PubMed ID: 8928281
    [Abstract] [Full Text] [Related]

  • 8. Oral contraceptive risks: a realistic appraisal.
    Bressler R, Durand JL.
    Drug Ther (NY); 1979 Oct 14; 9(10):81-95. PubMed ID: 12279276
    [Abstract] [Full Text] [Related]

  • 9. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
    Jick SS, Kaye JA, Russmann S, Jick H.
    Contraception; 2006 Jun 14; 73(6):566-70. PubMed ID: 16730485
    [Abstract] [Full Text] [Related]

  • 10. [Vascular disease and hormonal treatment--epidemiology].
    Vessey MP.
    Contracept Fertil Sex (Paris); 1985 Jan 14; 13(1 Suppl):121-6. PubMed ID: 12280197
    [Abstract] [Full Text] [Related]

  • 11. Relationship of migraine headache and stroke to oral contraceptive use.
    Benson MD, Rebar RW.
    J Reprod Med; 1986 Dec 14; 31(12):1082-8. PubMed ID: 3540297
    [Abstract] [Full Text] [Related]

  • 12. [Oral contraception and cerebral embolisms].
    Riedel M, Lichtlen PR.
    Dtsch Med Wochenschr; 1993 Oct 15; 118(41):1506-7. PubMed ID: 8404516
    [Abstract] [Full Text] [Related]

  • 13. Estrogen dose in oral contraceptives: FDA committee examines safety and utility of 50 mcg estrogen OCs.
    Contracept Rep; 1994 Mar 15; 5(1):10-3. PubMed ID: 12287738
    [Abstract] [Full Text] [Related]

  • 14. [Cerebral thromboembolism, oral contraceptives and pregnancy].
    Lidegaard O, Andersen MV, Søe M.
    Ugeskr Laeger; 1987 Aug 03; 149(32):2135-7. PubMed ID: 3450019
    [Abstract] [Full Text] [Related]

  • 15. Oral contraceptive use and venous thromboembolism: a consideration of the impact of bias and confounding factors on epidemiological studies.
    Rekers H, Norpoth T, Michaels MA.
    Eur J Contracept Reprod Health Care; 1996 Aug 03; 1(1):21-30. PubMed ID: 9678134
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC.
    Contracept Fertil Sex (Paris); 1991 Apr 03; 19(4):285-8. PubMed ID: 12343220
    [Abstract] [Full Text] [Related]

  • 18. Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users.
    Cole JA, Norman H, Doherty M, Walker AM.
    Obstet Gynecol; 2007 Feb 03; 109(2 Pt 1):339-46. PubMed ID: 17267834
    [Abstract] [Full Text] [Related]

  • 19. [The pill and thrombosis].
    Thranov I, Obel EB.
    Ugeskr Laeger; 1984 Sep 03; 146(36):2709-11. PubMed ID: 6515890
    [Abstract] [Full Text] [Related]

  • 20. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.
    Gammon MD, Hibshoosh H, Terry MB, Bose S, Schoenberg JB, Brinton LA, Bernstein JL, Thompson WD.
    Cancer Epidemiol Biomarkers Prev; 1999 May 03; 8(5):413-9. PubMed ID: 10350436
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.